To access the localized content, select the website associated with the Division of your interest:

Health & Safety

    Healthcare & Life Sciences

      Energy & Mobility

        Investor Relations

        Press Releases

        Press releases

        1. GVS approves consolidated results as at 31 March 2021
          Price Sensitive
        2. The GVS Board of Directors approves the 2020 financial statement: revenues up 60%, strong growth in Group profitability and solid increase in all key economic and financial indicators
          Price Sensitive
        3. GVS S.p.A. – Financial Calendar 2021
          Price Sensitive

        1. GVS approves the consolidated results at 30 September 2020 revenue up 49.6% and marked growth of the Group’s profit margin.
          Price Sensitive
        2. The bod of GVS S.p.A. Approves the first half 2020 results revenue at 30 june 2020 up 25% and considerable growth in profit margin.
          Price Sensitive
        3. GVS: completion of the Closing of the acquisition of Haemonetics Puerto Rico, LLC,
          Price Sensitive
        4. GVS S.p.A. – Financial Calendar 2020.
          Price Sensitive
        5. GVS announces the agreement to acquire Puerto Rico-based manufacturing operations of Haemonetics.

        This website uses first-party and third-party cookies in order to offer dynamic content and a better user experience. For further information please read our Privacy Policy.